ESEPAPOGENE ZALARNAREPVEC EXPRESSED LYMPHOCYTIC CHORIOMENINGITIS VIRUS PRE-GLYCOPROTEIN POLYPROTEIN GP
UNII 337VS7CVU8

Substance Identification & Data

This profile provides standardized clinical and technical data for Esepapogene Zalarnarepvec Expressed Lymphocytic Choriomeningitis Virus Pre-glycoprotein Polyprotein Gp, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 337VS7CVU8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
337VS7CVU8
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ESEPAPOGENE ZALARNAREPVEC EXPRESSED LYMPHOCYTIC CHORIOMENINGITIS VIRUS PRE-GLYCOPROTEIN POLYPROTEIN GP
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Esepapogene Zalarnarepvec Expressed Lymphocytic Choriomeningitis Virus Pre-glycoprotein Polyprotein Gp. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ESEPAPOGENE ZALARNAREPVEC EXPRESSED LYMPHOCYTIC CHORIOMENINGITIS VIRUS PRE-GLYCOPROTEIN POLYPROTEIN GP
TT1-E7E6 EXPRESSED PRE-GLYCOPROTEIN POLYPROTEIN GP
VSV-GP128 EXPRESSED LYMPHOCYTIC CHORIOMENINGITIS VIRUS PRE-GLYCOPROTEIN POLYPROTEIN GP

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record